BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2234178)

  • 1. [The 'freckle bus' campaign; an unhealthy phenomenon or a sensible experiment?].
    Krol AD; van der Rhee HJ; Dieleman M; Welvaart K
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2047-50. PubMed ID: 2234178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for skin cancer in The Netherlands.
    Krol S; Keijser LM; van der Rhee HJ; Welvaart K
    Acta Derm Venereol; 1991; 71(4):317-21. PubMed ID: 1681648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant melanoma in a primary care pathologico-anatomical laboratory in 1988 and the freckle bus year].
    Bosch MM; Boon ME
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2051-4. PubMed ID: 2234179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of melanoma: an educational campaign in Padova, Italy.
    Rossi CR; Vecchiato A; Bezze G; Mastrangelo G; Montesco MC; Mocellin S; Meneghetti G; Mazzoleni F; Peserico A; Nitti D; Lise M
    Melanoma Res; 2000 Apr; 10(2):181-7. PubMed ID: 10803719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.
    Seidenari S; Benati E; Ponti G; Borsari S; Ferrari C; Albertini G; Altomare G; Arcangeli F; Aste N; Bernengo MG; Bongiorno MR; Borroni G; Calvieri S; Chimenti S; Cusano F; Fracchiolla C; Gaddoni G; Girolomoni G; Guarneri B; Lanzoni A; Lombardi M; Lotti T; Mariotti A; Marsili F; Micali G; Parodi A; Peris K; Peserico A; Quaglino P; Santini M; Schiavon S; Tonino C; Trevisan G; Tribuzi P; Valentini P; Vena GA; Virgili A
    Eur J Cancer Prev; 2012 Jan; 21(1):89-95. PubMed ID: 22001916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes from skin screening clinics within a community-based melanoma screening program.
    Aitken JF; Janda M; Elwood M; Youl PH; Ring IT; Lowe JB
    J Am Acad Dermatol; 2006 Jan; 54(1):105-14. PubMed ID: 16384764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin cancer screening focusing on melanoma yields more selective attendance.
    de Rooij MJ; Rampen FH; Schouten LJ; Neumann HA
    Arch Dermatol; 1995 Apr; 131(4):422-5. PubMed ID: 7726583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece.
    Stratigos A; Nikolaou V; Kedicoglou S; Antoniou C; Stefanaki I; Haidemenos G; Katsambas AD
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):56-62. PubMed ID: 17207168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions of skin cancer incidence in the Netherlands up to 2015.
    de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
    Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 'freckle bus'; an unhealthy phenomenon or a sober-minded experiment?].
    Rampen FH
    Ned Tijdschr Geneeskd; 1991 Feb; 135(7):295. PubMed ID: 2020333
    [No Abstract]   [Full Text] [Related]  

  • 11. Total skin examination during screening for malignant melanoma does not increase the detection rate.
    De Rooij MJ; Rampen FH; Schouten LJ; Neumann HA
    Br J Dermatol; 1996 Jul; 135(1):42-5. PubMed ID: 8776357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of malignant melanoma in an "open house" setting].
    Poulsen AG; Larsen FG; Weismann K; Petersen CS; Ravnborg LR; Heidenheim M; Lauritzen TE; Held E; Osterlind AL
    Ugeskr Laeger; 1999 Mar; 161(12):1758-61. PubMed ID: 10210976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of skin cancer screening in West Virginia.
    Jubelirer SJ; Carper M; Farmer DE; Milroy SK; Parsons NC; Reynolds HR; Skaff KL
    W V Med J; 1991 Feb; 87(2):57-60. PubMed ID: 2006560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of dermatologic screening within the frame work of a general cancer prevention program].
    Lacava V; Salesi N; Ferrone L; Veri A; Lembo R; Masi MC; Rocchi M; Rondinelli R; Parisi E; Grieco T; Balzani A; Clerico R; Innocenzi D; Bottoni U; Calvieri S
    Minerva Med; 2001 Apr; 92(2):85-8. PubMed ID: 11323570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
    van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
    Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of skin cancer incidence in the Hamilton area.
    Freeman NR; Fairbrother GE; Rose RJ
    N Z Med J; 1982 Aug; 95(713):529-33. PubMed ID: 6957767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program.
    Jonna BP; Delfino RJ; Newman WG; Tope WD
    Prev Med; 1998; 27(4):611-6. PubMed ID: 9672956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer screening campaign in the German speaking Community of Belgium.
    Nikkels AF; Nikkels-Tassoudji N; Jerusalem-Noury E; Sandman-Lobusch H; Sproten G; Zeimers G; Schroeder J; Piérard GE
    Acta Clin Belg; 2004; 59(4):194-8. PubMed ID: 15597726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1989 Bochum health education program for malignant melanoma].
    Hoffmann K; Matthes U; Stücker M; Segerling M; Altmeyer P
    Offentl Gesundheitswes; 1990 Jan; 52(1):9-13. PubMed ID: 2138274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin cancer screening program in the population of Bydgoszcz].
    Mierzwa T; Zegarski W; Placek W; Zegarska B
    Wiad Lek; 2004; 57 Suppl 1():211-4. PubMed ID: 15884241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.